Replies to post #149452 on Cytodyn Inc (CYDY)

[justdafactss]

From the July 21, 2020 PR- Nader Pourhassan, Ph.D. President and Chief Executive Officer of CytoDyn, concluded, “We are very pleased to see clear advantages for the patients in this population in leronlimab versus placebo in regards to SAEs and look forward to announcing all of the efficacy endpoints very soon
https://finance.yahoo.com/news/impressive-results-cytodyn-phase-2-155010413.html

Did CYDY ever announce the efficacy endpoints or not?

[Bill_ENG]

That's right ! Is it " I am eager to win " or " I am eager to lose " ?

I don't know anyone who is eager to lose.